Dr. Yi-Ting Chiu is the Molecular Pharmacology Highlighted Trainee Author for November 2017.

Dr. Chiu is currently a postdoctoral fellow in the Center for Substance Abuse Research and Department of Pharmacology at Temple University Lewis Katz School of Medicine. The Molecular Pharmacology article that earned her selection as a Highlighted Trainee Author is titled "Agonist-Dependent and -Independent κ Opioid Receptor Phosphorylation: Distinct Phosphorylation Patterns and Different Cellular Outcomes".

Dr. Chiu’s area of research is the cellular pharmacology of the kappa opioid receptor (KOPR). Currently, she is working on KOPR phosphorylation to examine the underlying mechanisms. In particular, she is interested in how different protein kinases regulate diverse phosphorylation patterns on KOPR.

The potential impact of Dr. Chiu’s current research is to define how different agonists cause distinct KOPR phosphorylation patterns via protein kinases, leading to different cellular outcomes. Characterizations of KOPR phosphorylation patterns may be used as a screening tool for development of KOPR agonists with reduced side effects.

When not in the lab, Dr. Chiu enjoys traveling to explore the beauty of nature. She likes to experience different cultures.